JPH0417634B2 - - Google Patents

Info

Publication number
JPH0417634B2
JPH0417634B2 JP9262387A JP9262387A JPH0417634B2 JP H0417634 B2 JPH0417634 B2 JP H0417634B2 JP 9262387 A JP9262387 A JP 9262387A JP 9262387 A JP9262387 A JP 9262387A JP H0417634 B2 JPH0417634 B2 JP H0417634B2
Authority
JP
Japan
Prior art keywords
carrier
chitosan
porous chitosan
amount
physiologically active
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP9262387A
Other languages
Japanese (ja)
Other versions
JPS63258579A (en
Inventor
Mitsunori Itoyama
Hiroaki Yabe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fuji Spinning Co Ltd
Original Assignee
Fuji Spinning Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fuji Spinning Co Ltd filed Critical Fuji Spinning Co Ltd
Priority to JP9262387A priority Critical patent/JPS63258579A/en
Publication of JPS63258579A publication Critical patent/JPS63258579A/en
Publication of JPH0417634B2 publication Critical patent/JPH0417634B2/ja
Granted legal-status Critical Current

Links

Description

【発明の詳細な説明】 〓産業上の利用分野〓 本発明はアミノ基を有する酵素等の生理活性物
質を固定化させるのに好適な担体の製造法に関す
るものである。
DETAILED DESCRIPTION OF THE INVENTION Field of Industrial Application The present invention relates to a method for producing a carrier suitable for immobilizing a physiologically active substance such as an enzyme having an amino group.

〓従来の技術〓 従来、キトサンを用いて生理活性物質を固定化
させるために、キトサンのアミノ基を利用してグ
ルタールアルデヒド等のジアルデヒドを用いるこ
とはかなり以前より知られており、又、カルボジ
イミド試薬によるペプチド結合による方法も特公
昭53−10150号に開示されている。本発明者等は
先に特願昭60−210731号(特開昭62−70401号)
として多孔質キトサン粒状体をN−アセチル化
し、多孔質キチン粒状体となし、架橋剤で処理後
カルボキシアルキル化しその後で脱アセチル化処
理して担体を得ること、特願昭60−218980号(特
開昭62−79201号)として多孔質キトサン粒状体
を有機溶媒中でアシル化剤で処理して担体を得る
方法、特願昭61−188259号で(特開昭63−44884
号)で多孔質キトサン粒状体をジカルボン酸誘導
体で架橋後アセチル化して担体を得ること、又、
特願昭61−188260号(特開昭63−44887号)で多
孔質キトサン粒状体を過剰のジカルボン酸エステ
ルで処理する方法を提案している。
〓Conventional technology〓 It has been known for a long time that dialdehydes such as glutaraldehyde are used by utilizing the amino groups of chitosan to immobilize physiologically active substances using chitosan. A method using a peptide bond using a carbodiimide reagent is also disclosed in Japanese Patent Publication No. 10150/1983. The inventors previously filed Japanese Patent Application No. 60-210731 (Japanese Unexamined Patent Publication No. 62-70401).
As described in Japanese Patent Application No. 60-218980, porous chitosan particles are N-acetylated to obtain porous chitin particles, treated with a crosslinking agent, carboxyalkylated, and then deacetylated to obtain a carrier. A method for obtaining a carrier by treating porous chitosan particles with an acylating agent in an organic solvent is disclosed in Japanese Patent Application No. 61-188259 (Japanese Patent Application Laid-open No. 63-44884).
No.), crosslinking porous chitosan granules with a dicarboxylic acid derivative and then acetylating them to obtain a carrier;
Japanese Patent Application No. 61-188260 (Japanese Unexamined Patent Publication No. 63-44887) proposes a method of treating porous chitosan particles with an excess of dicarboxylic acid ester.

〓発明が解決しようとする問題点〓 多孔質キトサン粒状体をグルタールアルデヒド
等のジアルデヒドで処理して担体とした場合、酵
素等を固定化するときにアミノ基とアルデヒド基
間が、シツフ塩基の形で結合するために酸に弱い
性質となつてしまう。また還元すれば結合は強く
なるが、酵素等が変性し易いものでは使用する還
元剤との処理方法が限定されてしまう欠点があ
る。又、カルポジイミドで処理する場合には酵素
等との結合がアミド結合となり、酸、アルカリに
対する性質は改善されるが固定化に際してのPH調
節に手間を要し、酵素等を変性させる可能性が大
きい。ジカルボン酸活性エステルで処理した担体
では酵素等の固定はアミド結合によるものであ
り、しかも温和な条件で固定化が可能であるが、
残存アミノ基が必ず生じるために、アミノ基のイ
オン性による非特異的吸着を生じる可能性が大き
い。
〓Problems to be solved by the invention〓 When porous chitosan particles are treated with a dialdehyde such as glutaraldehyde and used as a carrier, when immobilizing enzymes, etc., the gap between the amino group and the aldehyde group becomes Schiff base. Because it bonds in the form of , it becomes vulnerable to acids. Further, although reduction strengthens the bond, if the enzyme is easily denatured, there is a drawback that the method of treatment with the reducing agent used is limited. Furthermore, when treated with carposiimide, the bond with the enzyme, etc. becomes an amide bond, which improves the properties against acids and alkalis, but requires time and effort to adjust the pH during immobilization, and there is a high possibility of denaturing the enzyme, etc. . In carriers treated with dicarboxylic acid active esters, enzymes, etc. can be immobilized through amide bonds, and can be immobilized under mild conditions.
Since residual amino groups are inevitably generated, there is a high possibility that non-specific adsorption will occur due to the ionic nature of the amino groups.

本発明は、上述の欠点を解決し、耐酸性に勝れ
固定化も容易であつて、更に固定化後の非特異的
吸着をも解決した生理活性物質固定化用担体を得
ることを目的とする。
The purpose of the present invention is to solve the above-mentioned drawbacks, to obtain a carrier for immobilizing physiologically active substances that has excellent acid resistance, is easy to immobilize, and also solves non-specific adsorption after immobilization. do.

〓問題点を解決するための手段〓 本発明は、カルボキシル基を有する粒状多孔質
キトサン誘導体を、ジシクロヘキシルカルボジイ
ミドの等のカルボジイミド類結合剤と、N−ヒド
ロキシコハク酸イミドで処理する生理活性物質固
定化用担体の製造法である。
〓Means for solving the problems〓 The present invention provides immobilization of physiologically active substances by treating a granular porous chitosan derivative having a carboxyl group with a carbodiimide binder such as dicyclohexylcarbodiimide and N-hydroxysuccinimide. This is a method for producing carriers for

多孔質キトサン粒状体は、先に特開昭61−
40337号で開示した方法によつて得ることができ
る。多孔質トキサン粒状体の製造に使用するキト
サンは、特に限定はないが平均分子量が10000〜
230000の低分子量キトサンを用いることが好まし
い。キトサンは酢酸、ジクロル酢酸、蟻酸等の単
独若しくは混合物の水溶液に溶解し、キトサン酸
性水溶液とする。キトサン酸性水溶液の濃度は2
〜20%が好ましい。該キトサン酸性水溶液は、水
酸化ナトリウム、水酸化カリウム、炭酸ナトリウ
ム、炭酸カリウム、アンモニア、エチレンジアミ
ン等のアルカリ性物質を含む塩基性水溶液中で凝
固再生させる。この時、塩基性水溶液にアルコー
ル等を加えて使用することもできる。
Porous chitosan granules were first published in Japanese Patent Application Laid-Open No. 1986-
It can be obtained by the method disclosed in No. 40337. The chitosan used in the production of porous toxane granules is not particularly limited, but has an average molecular weight of 10,000 to 10,000.
Preferably, a low molecular weight chitosan of 230,000 is used. Chitosan is dissolved in an aqueous solution of acetic acid, dichloroacetic acid, formic acid, etc. alone or in a mixture to obtain an acidic chitosan aqueous solution. The concentration of chitosan acidic aqueous solution is 2
~20% is preferred. The chitosan acidic aqueous solution is coagulated and regenerated in a basic aqueous solution containing an alkaline substance such as sodium hydroxide, potassium hydroxide, sodium carbonate, potassium carbonate, ammonia, and ethylenediamine. At this time, alcohol or the like may be added to the basic aqueous solution.

該キトサン水溶液を吐出孔より圧力下で塩基性
水溶液中に一定量づつ落下させて凝固再生させ、
中性になる迄充分水洗を行い、多孔質キトサンを
得る。多孔質キトサンは、必要に応じ、更に極性
溶媒中で有機ジイソシアネート化合物を用いて架
橋処理を行つてもよい。
The chitosan aqueous solution is allowed to solidify and regenerate by dropping a certain amount of the chitosan aqueous solution into the basic aqueous solution under pressure from the discharge hole,
Wash thoroughly with water until it becomes neutral to obtain porous chitosan. Porous chitosan may be further crosslinked using an organic diisocyanate compound in a polar solvent, if necessary.

上述の如くして得た多孔質キトサン粒状体から
カルボキシル基を有する粒状多孔質キトサン誘導
体を得るには、ジカルボン酸無水物によるアシル
化の方法、ジカルボン酸ハロゲン化物による方法
又はモノクロル酢酸等によるカルボキシアルキル
による方法等を採用すればよい。また、キトサン
の残存アミノ基をブロツクするために無水酢酸で
アミノ基をアセチル化させる。このようにして得
られたカルボキシル基を持つ粒状多孔質キトサン
誘導体を極性溶媒例えばジオキサン、ジメチルホ
ルムアミド、ジメチルアセトアミド、ジメチルス
ルホオキシド、テトラヒドロフラン等に懸濁させ
た後に、N−ヒドロキシコハク酸イミドを加え更
にジシクロヘキシルカルボジイミド等のカルボジ
イミド系の結合剤を加え数時間撹拌反応させる。
反応後、該粒状体を使用した極性溶媒で充分洗浄
することにより優れた生理活性物質固定化用担体
を得ることができる。
In order to obtain a granular porous chitosan derivative having a carboxyl group from the porous chitosan granules obtained as described above, acylation using a dicarboxylic acid anhydride, a method using a dicarboxylic acid halide, or carboxyalkyl conversion using a monochloroacetic acid, etc. A method such as that described above may be adopted. Furthermore, in order to block the remaining amino groups of chitosan, the amino groups are acetylated with acetic anhydride. After suspending the granular porous chitosan derivative having a carboxyl group thus obtained in a polar solvent such as dioxane, dimethylformamide, dimethylacetamide, dimethylsulfoxide, tetrahydrofuran, etc., N-hydroxysuccinimide is added and further A carbodiimide binder such as dicyclohexylcarbodiimide is added, and the reaction is stirred for several hours.
After the reaction, by thoroughly washing the granules with the polar solvent used, an excellent carrier for immobilizing a physiologically active substance can be obtained.

〓実施例〓 以下、本発明を実施例により説明するが、本発
明は実施例記載の範囲に限定されるものではな
い。尚、イオン交換容量及び比表面積は、下記の
方法により求めた。
〓Example〓 The present invention will be explained below with reference to Examples, but the present invention is not limited to the scope described in the Examples. Incidentally, the ion exchange capacity and specific surface area were determined by the following methods.

◎イオン交換容量 試料約50mlを1N−HCl500ml中でゆるやかに撹
拌しながら、1時間処理し、脱イオン水で中性に
なる迄充分洗浄し、空気中の炭酸ガスを吸収させ
ない様に注意しながら脱水した試料30mlを正確に
迅速に計りとり、1/5N−NaOH500ml中に投入
し、ゆるやかに撹拌しながら5時間放置する。こ
の上澄液を試験液とする。これを10ml搾取し、メ
チルレツド溶液を指示薬として1/10N−HClで中
和滴定し次式で求めた。
◎Ion exchange capacity Approximately 50 ml of the sample was treated in 500 ml of 1N HCl for 1 hour with gentle stirring, and thoroughly washed with deionized water until it became neutral, taking care not to absorb carbon dioxide gas in the air. Accurately and quickly measure out 30 ml of the dehydrated sample, add it to 500 ml of 1/5N-NaOH, and leave it for 5 hours with gentle stirring. This supernatant liquid is used as the test liquid. 10 ml of this was taken out and neutralized titrated with 1/10N-HCl using the methylred solution as an indicator to determine the amount using the following formula.

CTW(meq/g) =(b−a)×f×1/10×500/10/V×16 a:試験液10mlを中和するに要した1/10N−HCl
量 b:試料を入れる前の1/5N−NaOH 10mlを中
和するのに要した1/10N−NCl量 f:1/10N−HClの力価 V:湿潤試料量(30ml) ◎比表面積:比表面積測定装置を用いてBET法
で測定した。
CTW (meq/g) = (b-a) x f x 1/10 x 500/10/V x 16 a: 1/10 N-HCl required to neutralize 10 ml of test solution
Amount b: Amount of 1/10N-NCl required to neutralize 10ml of 1/5N-NaOH before adding the sample f: Titer of 1/10N-HCl V: Amount of wet sample (30ml) ◎Specific surface area: It was measured by the BET method using a specific surface area measuring device.

実施例 1 脱アセチル化度77%、平均分子量42000のキト
サン70gを3.5%酢酸水溶液930gに溶解し、該溶
液を7%の苛性ソーダ、30%のエタノール、63%
の水からなる混合溶液中に0.15mmφの孔径ノズル
から落下させ、凝固再生させた後、中性になるま
で水洗し、平均粒径0.1mmφの多孔質キトサン粒
状体0.8を得た。得られた多孔質キトサン粒状
体100ml(湿潤状態)に5.0gのヘキサメチレンジ
イソシアネートを加え、ジメチルホルムアミド中
で常温1時間撹拌反応させ架橋させた。ジメチル
ホルムアミドで洗浄後、ジメチルホルムアミド
100ml中12.2gの無水酢酸を加え、常温で24時間
撹拌しアミノ基をアセチル化させ、これを48°B′e
苛性ソーダで0℃、1時間浸潤後、イソプロピル
アルコールで充分洗浄し、イソプロピルアルコー
ル100ml中にモノクロル酢酸10gを加え1時間反
応させてカルボキシメチル化を行つた。水洗して
カルボキシル基を有する粒状多孔質キトサン誘導
体95mlを得た。これのイオン交換容量は
0.35meq/ml、比表面積は94m2/gであつた。該
粒状体50mlをジオキサン100ml中に懸濁した後、
ジシクロヘキシルカルボジイミドとN−ヒドロキ
シコハク酸イミドを共に0.1Mになる様に加え、
常温で2時間反応させジオキサンとメタノールで
充分洗浄して比表面積91m2/gの生理活性物質固
定化用担体48mlを得た。該担体1mlを1%ヘモグ
ロビン溶液(0.1Mホウ酸緩衝溶液、PH8.3)2ml
に加え、2時間振盪して固定化した。固定化量を
570nmの吸光度から測定した処、3.3mg/mlであ
つた。又、ヘモグロビンを固定化した担体を1ml
の1%牛血清アルブミン溶液(0.1Mトリスー
HCl緩衝液、PH7.4)2ml中に入れ、2時間振盪
し牛血清アルブミンを吸着させ、上澄液の280n
mにおける吸光度から吸着量を測定したら1.23
mg/mlで非特異的吸着が少なかつた。更にヘモグ
ロビンを固定化した担体の1mlを0.1N−HCl2ml
中に入れて15分振盪後上澄液の570nmにおける
吸光度によつて脱落量を測定したところ、0.05
mg/mlで殆ど酸に対する脱落もなかつた。
Example 1 70 g of chitosan with a degree of deacetylation of 77% and an average molecular weight of 42,000 was dissolved in 930 g of a 3.5% acetic acid aqueous solution, and the solution was mixed with 7% caustic soda, 30% ethanol, and 63% acetic acid.
was dropped into a mixed solution of water through a nozzle with a pore size of 0.15 mmφ, solidified and regenerated, and then washed with water until it became neutral to obtain porous chitosan particles with an average particle size of 0.1 mmφ. 5.0 g of hexamethylene diisocyanate was added to 100 ml of the obtained porous chitosan granules (in a wet state), and stirred and reacted in dimethylformamide at room temperature for 1 hour to cause crosslinking. After washing with dimethylformamide, dimethylformamide
Add 12.2 g of acetic anhydride in 100 ml, stir at room temperature for 24 hours to acetylate the amino groups, and add this to 48°B'e.
After soaking with caustic soda at 0°C for 1 hour, the mixture was thoroughly washed with isopropyl alcohol, and 10 g of monochloroacetic acid was added to 100 ml of isopropyl alcohol and reacted for 1 hour to carry out carboxymethylation. After washing with water, 95 ml of a granular porous chitosan derivative having carboxyl groups was obtained. The ion exchange capacity of this is
The specific surface area was 0.35 meq/ml and 94 m 2 /g. After suspending 50 ml of the granules in 100 ml of dioxane,
Add dicyclohexylcarbodiimide and N-hydroxysuccinimide to a total concentration of 0.1M,
The reaction mixture was allowed to react for 2 hours at room temperature and thoroughly washed with dioxane and methanol to obtain 48 ml of a carrier for immobilizing a physiologically active substance with a specific surface area of 91 m 2 /g. Add 1 ml of the carrier to 2 ml of 1% hemoglobin solution (0.1M borate buffer solution, PH8.3).
In addition, it was fixed by shaking for 2 hours. Immobilization amount
The absorbance at 570 nm was determined to be 3.3 mg/ml. In addition, 1 ml of carrier immobilized with hemoglobin
1% bovine serum albumin solution (0.1M Tris
Pour into 2 ml of HCl buffer (PH7.4) and shake for 2 hours to adsorb bovine serum albumin.
When the adsorption amount was measured from the absorbance at m, it was 1.23
There was little nonspecific adsorption at mg/ml. Furthermore, add 1 ml of the hemoglobin-immobilized carrier to 2 ml of 0.1N-HCl.
After shaking for 15 minutes, the amount of shedding was measured by the absorbance of the supernatant at 570 nm, and it was found to be 0.05.
At mg/ml, there was almost no shedding due to acid.

実施例 2 実施例1と同様にして得た粒状多孔質キトサン
100mlをエタノール100mlに懸濁させ無水コハク酸
2.0gを加え常温で24時間反応させた。その後エ
タノールで充分洗浄後エタノール100ml中に無水
酢酸12.2gを加え、1時間撹拌してアミノ基をブ
ロツクさせカルボキシル基を有するイオン交換容
量0.25meq/ml、比表面積63.5m2/gの多孔質キ
トサン誘導粒状体95mlを得た。該粒状多孔質キト
サン誘導体50mlを実施例1と同様にジオキサン中
でジシクロヘキシルカルボジイミドとN−ヒドロ
キシコハク酸イミドで活性エステル化して比表面
積72.3m2/gの生理活性物質固定化用担体40mlを
得た。
Example 2 Granular porous chitosan obtained in the same manner as Example 1
Suspend 100ml in 100ml of ethanol and add succinic anhydride.
2.0g was added and reacted at room temperature for 24 hours. After washing thoroughly with ethanol, 12.2 g of acetic anhydride was added to 100 ml of ethanol and stirred for 1 hour to block the amino groups and form porous chitosan with carboxyl groups, ion exchange capacity of 0.25 meq/ml, and specific surface area of 63.5 m 2 /g. 95 ml of induced granules were obtained. 50 ml of the granular porous chitosan derivative was esterified with dicyclohexylcarbodiimide and N-hydroxysuccinimide in dioxane in the same manner as in Example 1 to obtain 40 ml of a carrier for immobilizing a physiologically active substance with a specific surface area of 72.3 m 2 /g. .

該担体1mlを用いて実施例1と同様にヘモグロ
ビンを固定したところ、固定化量は8.4mg/mlで、
牛血清アルブミン吸着量は0.95mg/ml、0.1N−
HCl処理後の脱落量は0.06mg/mlで非特異吸着が
少なく、脱落が殆どないことが確認された。
When hemoglobin was immobilized in the same manner as in Example 1 using 1 ml of the carrier, the immobilized amount was 8.4 mg/ml,
Bovine serum albumin adsorption amount is 0.95mg/ml, 0.1N−
The amount of shedding after HCl treatment was 0.06 mg/ml, which confirmed that there was little non-specific adsorption and almost no shedding.

実施例 3 平均分子量45000、脱アセチル化度82%のキト
サン70gを3.5%酢酸水溶液930gに溶解し、該溶
液を10%の苛性ソーダ、30%のメタノール、60%
の水よりなる混合溶液中に0.15mmφの孔径ノズル
より落下させ、凝固再生させた後、中性になる迄
水洗し平均粒径0.3mmφの多孔質キトサン粒状体
1を得た。
Example 3 70 g of chitosan with an average molecular weight of 45,000 and a degree of deacetylation of 82% was dissolved in 930 g of a 3.5% acetic acid aqueous solution, and the solution was mixed with 10% caustic soda, 30% methanol, and 60%
The porous chitosan particles 1 were dropped into a mixed solution of water through a nozzle with a hole diameter of 0.15 mmφ, solidified and regenerated, and then washed with water until neutralized to obtain porous chitosan particles 1 with an average particle size of 0.3 mmφ.

該粒状体100mlをジオキサン100ml中でアジピン
酸ジクロリド8.3gとトリエチンアミン12.0gを
加え常温で1時間撹拌反応させた。その後充分エ
タノールで洗浄し、100mlエタノール中で12.2g
の無水酢酸を加え、常温24時間撹拌し残存アミノ
基をアセチル化し、充分水洗して交換容量
0.31meq/ml、比表面積85.2m2/gのカルボキシ
ル基を有する粒状多孔質キトサン誘導体88mlを得
た。
8.3 g of adipic acid dichloride and 12.0 g of triethinamine were added to 100 ml of the granules in 100 ml of dioxane, and the mixture was stirred and reacted at room temperature for 1 hour. After that, wash thoroughly with ethanol, and 12.2g in 100ml ethanol.
of acetic anhydride, stirred at room temperature for 24 hours to acetylate the remaining amino groups, and washed thoroughly with water to reduce the exchange capacity.
88 ml of a granular porous chitosan derivative having a carboxyl group with a specific surface area of 85.2 m 2 /g and a specific surface area of 0.31 meq/ml was obtained.

該粒状多孔質キトサン誘導体50mlを実施例1と
同様にジオキサン100ml中でジシクロヘキシルカ
ルボジイミドとN−ヒドロキシコハク酸イミドで
活性エステル化して、比表面積83.8m2/gの生理
活性物質固定化用担体45mlを得た。
50 ml of the granular porous chitosan derivative was active esterified with dicyclohexylcarbodiimide and N-hydroxysuccinimide in 100 ml of dioxane in the same manner as in Example 1 to obtain 45 ml of a carrier for immobilizing a physiologically active substance with a specific surface area of 83.8 m 2 /g. Obtained.

該担体1mlを用い実施例1と同様にヘモグロビ
ンを固定したところ、固定化量は12.3mg/ml、牛
血清アルブミンの吸着量は0.75mg/mlで、
0.1NHCl処理後の吸光度によつて測定した脱落
量は0.11mg/mlで非特異吸着が少なく脱落が殆ど
ないことが確認された。
When hemoglobin was immobilized using 1 ml of the carrier in the same manner as in Example 1, the immobilized amount was 12.3 mg/ml, and the adsorbed amount of bovine serum albumin was 0.75 mg/ml.
The amount of shedding measured by absorbance after treatment with 0.1NHCl was 0.11 mg/ml, which confirmed that non-specific adsorption was small and there was almost no shedding.

比較例 1 実施例1と同様の操作で得た多孔質キトサン粒
状体1mlを10%のグルタールアルデヒド水溶液2
mlに加えて常温で2時間振盪した後充分水洗し、
これに1%のヘモグロビン水溶液2mlを加えて常
温で2時間振盪してヘモグロビンを固定化した。
固定化量は14.3mg/mlである。この担体1mlに
0.1N−HClを加えて15分間振盪した結果7.0mg/
mlのヘモグロビンが脱落した。
Comparative Example 1 1 ml of porous chitosan granules obtained in the same manner as in Example 1 was added to 10% glutaraldehyde aqueous solution 2
ml, shake at room temperature for 2 hours, and then wash thoroughly with water.
To this was added 2 ml of a 1% hemoglobin aqueous solution, and the mixture was shaken at room temperature for 2 hours to fix hemoglobin.
The immobilized amount was 14.3 mg/ml. 1 ml of this carrier
After adding 0.1N-HCl and shaking for 15 minutes, the result was 7.0mg/
ml of hemoglobin was lost.

比較例 2 実施例3の方法で得られた多孔質キトサン粒状
体100mlを100mlのジメチルホルムアミドで洗浄し
た後、予め32gのアジピン酸ジ−N−ヒドロキシ
スクシイミドエステルを加温溶解したジメチルホ
ルムアミド500mlを加え、2時間70℃で撹拌し架
橋反応を行つた。反応後ジメチルホルムアミド
500mlで四回洗浄し、更に水で洗つてジメチルホ
ルムアミドを除去して比表面積88.3m2/gの担体
を得た。この担体1mlにヘモグロビン1%溶液
(01Mホウ酸緩衝溶液、PH8.3)2mlを加え室温で
2時間振盪したところ、13.4mg/mlのヘモグロビ
ンが固定化された。このヘモグロビンが固定化担
体1mlを1%牛血清アルブミン溶液(0.1Mトリ
ス−HCl緩衝溶液、PH7.4)2ml中に入れ牛血清
アルブミンの吸着量を残液の吸光度から測定した
ところ、5.3mg/mlの牛血清アルブミンが吸着さ
れ、比特異吸着が大きいことが示された。
Comparative Example 2 After washing 100 ml of porous chitosan granules obtained by the method of Example 3 with 100 ml of dimethylformamide, 500 ml of dimethylformamide in which 32 g of adipic acid di-N-hydroxysuccinimide ester had been dissolved in advance by heating was added. was added and stirred at 70°C for 2 hours to carry out a crosslinking reaction. Dimethylformamide after reaction
The carrier was washed four times with 500 ml and further washed with water to remove dimethylformamide to obtain a carrier having a specific surface area of 88.3 m 2 /g. When 2 ml of a 1% hemoglobin solution (01M borate buffer, pH 8.3) was added to 1 ml of this carrier and the mixture was shaken at room temperature for 2 hours, 13.4 mg/ml of hemoglobin was immobilized. When 1ml of this hemoglobin-immobilized carrier was placed in 2ml of 1% bovine serum albumin solution (0.1M Tris-HCl buffer solution, PH7.4) and the amount of bovine serum albumin adsorbed was measured from the absorbance of the remaining solution, it was found to be 5.3mg/ ml of bovine serum albumin was adsorbed, indicating a high specific adsorption.

〓発明の効果〓 本発明よる生理活性物質固定化担体は、多孔性
で比表面積の大きい粒状多孔質キトサン誘導体か
ら得られるものであるので、比表面積が大きく、
吸着量が大きく、特に耐酸性に勝れている点に特
徴がある。更に、本発明による生理活性物質固定
化用担体は、カルボキシル基を有する粒状多孔質
キトサン誘導体をカルボジイミド類結合剤を用い
てN−ヒドロキシコハク酸イミドで処理したもの
であり、また、残存アミノ基がブロツクされてい
るので、比特異吸着を極めて少なくすることが可
能である。
Effects of the Invention The physiologically active substance immobilized carrier according to the present invention is obtained from a granular porous chitosan derivative that is porous and has a large specific surface area.
It is characterized by a large amount of adsorption and particularly excellent acid resistance. Furthermore, the carrier for immobilizing a physiologically active substance according to the present invention is obtained by treating a granular porous chitosan derivative having carboxyl groups with N-hydroxysuccinimide using a carbodiimide binder, and in which residual amino groups are Since it is blocked, specific adsorption can be extremely reduced.

Claims (1)

【特許請求の範囲】 1 カルボキシル基を有する粒状多孔質キトサン
誘導体をジシクロヘキシルカルボジイミドとN−
ヒドロキシコハク酸イミドで処理することを特徴
とする生理活性物質固定化用担体の製造法。 2 該カルボキシル基を有する粒状多孔質キトサ
ン誘導体の残存アミノ基がアセチル化されている
ものであることを特徴とする特許請求の範囲第1
項に記載の生理活性物質固定化用担体の製造法。
[Claims] 1. A granular porous chitosan derivative having a carboxyl group is mixed with dicyclohexylcarbodiimide and N-
A method for producing a carrier for immobilizing a physiologically active substance, which comprises treating with hydroxysuccinimide. 2. Claim 1, characterized in that the residual amino groups of the granular porous chitosan derivative having carboxyl groups are acetylated.
A method for producing a carrier for immobilizing a physiologically active substance as described in 2.
JP9262387A 1987-04-15 1987-04-15 Production of carrier for immobilization of physiologically active substance Granted JPS63258579A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP9262387A JPS63258579A (en) 1987-04-15 1987-04-15 Production of carrier for immobilization of physiologically active substance

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP9262387A JPS63258579A (en) 1987-04-15 1987-04-15 Production of carrier for immobilization of physiologically active substance

Publications (2)

Publication Number Publication Date
JPS63258579A JPS63258579A (en) 1988-10-26
JPH0417634B2 true JPH0417634B2 (en) 1992-03-26

Family

ID=14059565

Family Applications (1)

Application Number Title Priority Date Filing Date
JP9262387A Granted JPS63258579A (en) 1987-04-15 1987-04-15 Production of carrier for immobilization of physiologically active substance

Country Status (1)

Country Link
JP (1) JPS63258579A (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5665702A (en) * 1995-06-06 1997-09-09 Biomeasure Incorporated Ionic molecular conjugates of N-acylated derivatives of poly(2-amino-2-deoxy-D-glucose) and polypeptides
US6479457B2 (en) 1995-06-06 2002-11-12 Kinerton Limited Ionic molecular conjugates of N-acylated derivatives of poly(2-amino-2-deoxy-D-glucose) and polypeptides
KR100449889B1 (en) * 2001-08-30 2004-09-22 동국제약 주식회사 Liposome for Containing Anion Polymer and Phospholipid and Manufacturing Method the Same and Application
CN111672480A (en) * 2020-06-18 2020-09-18 威海海洋职业学院 Crosslinked chitosan-multi-carbon nanotube composite material and application thereof

Also Published As

Publication number Publication date
JPS63258579A (en) 1988-10-26

Similar Documents

Publication Publication Date Title
US3947352A (en) Polysaccharide matrices for use as adsorbents in affinity chromatography techniques
Cuatrecasas Protein purification by affinity chromatography: derivatizations of agarose and polyacrylamide beads
EP0759760B1 (en) Wound healing agent
JP5208707B2 (en) Method for producing oxidized cellulose
US4141857A (en) Support matrices for immobilized enzymes
US4560504A (en) Carboxyl anchored immobilized antibodies
DE102006055558A1 (en) Adsorbent for removing endotoxins from solutions comprises a ligand in the form of an amine-functional molecule in which some of the amine groups are modified with an amine-reactive molecule
KR940005581B1 (en) Method for immobilization of enzyme and immobilized enzymes
Wilchek et al. Stable, high capacity and non charged agarose derivatives for immobilization of biologically active compounds and for affinity chromatography
JPH0417634B2 (en)
JPS6141608B2 (en)
JPH0369374B2 (en)
JPH05340948A (en) Transovarial antibody fixed carrier and fixing method
JPH0718848B2 (en) Method for manufacturing carrier for affinity chromatography
Valentova et al. Pepsin immobilized by covalent fixation to hydroxyalkyl methacrylate gels: preparation and characterization
JPH0236233B2 (en)
WO1983000345A1 (en) Immobilized cholinesterase enzyme preparations and a process for the preparation thereof
JPH03288546A (en) Production of water-insoluble tannin agent
JPH05261281A (en) Carrier for immobilizing bioactive substance and its production
JPH0211601B2 (en)
JPH0662680B2 (en) Method for producing carrier for immobilizing antibody
JPS6348453A (en) Carrier for chromatography and its production
JPH0359080B2 (en)
JPH0759567A (en) Carrier for immobilizing physiologically active substance
JPS6348452A (en) Adsorption carrier for chromatography

Legal Events

Date Code Title Description
LAPS Cancellation because of no payment of annual fees